Genetic evolution of influenza viruses among selected countries in Latin America, 2017-2018.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Leite Juliana Almeida, Resende Paola, Araya Jenny Lara, Barrera Gisela Badillo, Baumeister Elsa, Caicedo Alfredo Bruno, Coppola Leticia, de Mello Wyller Alencar, de Mora Domenica, Cordeiro Dos Santos Mirleide, Fasce Rodrigo, Fernández Jorge, Goñi Natalia, Martínez Irma López, Mayhua Jannet Otárola, Motta Fernando, Nuñez Maribel Carmen Huaringa, Ojeda Jenny, Ortega María José, Ospitia Erika, Paiva Terezinha Maria de, Pontoriero Andrea, Porras Hebleen Brenes, Quinonez Jose Alberto Diaz, Ramas Viviana, Ramírez Juliana Barbosa, Santos Katia Correa de Oliveira, Siqueira Marilda Mendonça, Vàzquez Cynthia, Palekar Rakhee
Аннотация
METHODS: We analyzed influenza A/H1pdm09, A/H3, B/Victoria and B/Yamagata hemagglutinin sequences from clinical samples from 12 National Influenza Centers (NICs) in ten countries (Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, Paraguay, Peru and Uruguay) with a collection date from epidemiologic week (EW) 18, 2017 through EW 43, 2018. These sequences were generated by the NIC or the WHO Collaborating Center (CC) at the U.S Centers for Disease Control and Prevention, uploaded to the Global Initiative on Sharing All Influenza Data (GISAID) platform, and used for phylogenetic reconstruction.
FINDINGS: Influenza hemagglutinin sequences from the participating countries (A/H1pdm09 n = 326, A/H3 n = 636, B n = 433) were highly concordant with the genetic groups of the influenza vaccine-recommended viruses for influenza A/H1pdm09 and influenza B. For influenza A/H3, the concordance was variable.
CONCLUSIONS: Considering the constant evolution of influenza viruses, high-quality surveillance data-specifically genetic sequence data, are important to allow public health decision makers to make informed decisions about prevention and control strategies, such as influenza vaccine composition. Countries that conduct influenza genetic sequencing for surveillance in LA should continue to work with the WHO CCs to produce high-quality genetic sequence data and upload those sequences to open-access databases.